Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum

被引:24
作者
Rothblat, DS
Schneider, JS
机构
[1] Dept. of Neurobiology and Anatomy, MS 408, Allegheny Univ. Hlth. S., Philadelphia
关键词
neuroleptics; electrochemistry; tardive dyskinesia;
D O I
10.1016/S0304-3940(97)00377-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study examined the extent to which local application of the typical neuroleptic haloperidol (HAL) or the atypical neuroleptic clozapine (CLOZ) influences dopamine (DA) transporter function in the dorsal and ventral striatum. Using urethane-anesthetized rats, DA was pressure ejected and monitored with in vivo electrochemistry, into the dorsal and ventral striatum to establish regional baseline DA reuptake rates. Haloperidol or CLOZ (10 mu M) was then applied, followed 5 min later by DA, in order to assess drug effects on DA reuptake rates. Haloperidol caused a 62% decrease in dorsal striatal DA reuptake rates while CLOZ had no effect on reuptake rates. Neither neuroleptic significantly altered DA reuptake rates in the ventral striatum. It is possible that HAL-induced decrease in DA reuptake in the sensorimotor striatum could be related to the motor side effect profile of this neuroleptic. Additional studies with other typical and atypical neuroleptics are needed to further evaluate the relationship between slowing of DA reuptake and the side effect potential of neuroleptic agents. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 24 条
[1]   SUBCORTICAL EXCITATORY AMINO-ACID LEVELS AFTER ACUTE AND SUBCHRONIC ADMINISTRATION OF TYPICAL AND ATYPICAL NEUROLEPTICS [J].
BARDGETT, ME ;
WRONA, CT ;
NEWCOMER, JW ;
CSERNANSKY, JG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) :245-250
[2]   LOCALIZATION OF DOPAMINE-D3 RECEPTOR MESSENGER-RNA IN THE RAT-BRAIN USING INSITU HYBRIDIZATION HISTOCHEMISTRY - COMPARISON WITH DOPAMINE-D2 RECEPTOR MESSENGER-RNA [J].
BOUTHENET, ML ;
SOUIL, E ;
MARTRES, MP ;
SOKOLOFF, P ;
GIROS, B ;
SCHWARTZ, JC .
BRAIN RESEARCH, 1991, 564 (02) :203-219
[3]  
BOYSON SJ, 1988, J PHARMACOL EXP THER, V244, P987
[4]   DIRECT IN-VIVO EVIDENCE THAT D2 DOPAMINE-RECEPTORS CAN MODULATE DOPAMINE UPTAKE [J].
CASS, WA ;
GERHARDT, GA .
NEUROSCIENCE LETTERS, 1994, 176 (02) :259-263
[5]   INCREASED DOPAMINE CLEARANCE IN THE NON-LESIONED STRIATUM OF RHESUS-MONKEYS WITH UNILATERAL 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) STRIATAL LESIONS [J].
CASS, WA ;
GERHARDT, GA ;
ZHANG, ZM ;
OVADIA, A ;
GASH, DM .
NEUROSCIENCE LETTERS, 1995, 185 (01) :52-55
[6]  
CHIODO LA, 1983, J NEUROSCI, V3, P1607
[7]   DOPAMINE D-2 AND D-3 RECEPTOR PREFERRING ANTAGONISTS DIFFERENTIALLY AFFECT STRIATAL DOPAMINE RELEASE AND METABOLISM IN CONSCIOUS RATS [J].
GAINETDINOV, RR ;
GREKHOVA, TV ;
SOTNIKOVA, TD ;
RAYEVSKY, KS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) :327-331
[8]  
ICHIKAWA J, 1991, J PHARMACOL EXP THER, V256, P348
[9]  
INNERNIZZI R, 1995, BRAIN RES, V670, P165
[10]   STUDY OF NEUROPATHOLOGIC CHANGES IN THE STRIATUM FOLLOWING 4, 8 AND 12 MONTHS OF TREATMENT WITH FLUPHENAZINE IN RATS [J].
JESTE, DV ;
LOHR, JB ;
MANLEY, M .
PSYCHOPHARMACOLOGY, 1992, 106 (02) :154-160